Evaluation of the Pharmacokinetics of the Pancreastatin Inhibitor PSTi8 Peptide in Rats: Integration of In Vitro and In Vivo Findings

PSTi8 is a pancreastatin inhibitory peptide that is effective in the treatment of diabetic models. This study investigates the pharmacokinetic (PK) properties of PSTi8 in Sprague Dawley rats, for the first time. In vitro and in vivo PK studies were performed to evaluate the solubility, stability in...

Descrición completa

Detalles Bibliográficos

Principais autores:	Guru R. Valicherla, Roshan A. Katekar, Shailesh Dadge, Mohammed Riyazuddin, Anees A. Syed, Sandeep K. Singh, Athar Husain, Muhammad Wahajuddin, Jiaur R. Gayen
Formato:	Artigo
Idioma:	Inglês
Publicado:	MDPI AG 2022-01-01
Series:	Molecules
Assuntos:	antidiabetic drugs PSTi8 in vitro ADME in vivo pharmacokinetics bioavailability
Acceso en liña:	https://www.mdpi.com/1420-3049/27/2/339
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!